amgen glp-1 obesity drug market potential 2025 Anti-obesity Drugs Growth Trend Analysis GLP-1 Receptor Agonist Market Size
Description
Novo Nordisk intends to launch the
Mounjaro Vision Problems and Eye Side Effects Mounjaro (tirzepatide) patients may be at an increased risk for adverse side effects such as sudden, painless vision loss in one eye due to NAION, temporary blurry vision from fluctuating blood sugar levels, and an increased risk of eye infections
This was observed for patients with and without diabetes
M.LalanneG.SchweizerA.DunningB
[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Waijer SW, Vart P, Cherney DZ, Chertow GM, Jongs N, Langkilde AM, et al
